MedPath

Clinical Efficiency of Bioactive Pit and Fissure Sealant

Phase 2
Not yet recruiting
Conditions
Pit and Fissure Sealant
Interventions
Other: UltraSeal XT™ plus by Ultradent
Other: BioCoat® by Premier®
Registration Number
NCT06493942
Lead Sponsor
Cairo University
Brief Summary

This study will compare the performance of newly introduced bioactive resin based pits and fissure sealant versus fluoride releasing filled resin based pits and fissure sealant in posterior molars prone to carious lesions of fissures in patients at risk of caries. Visual tactile examination and VistaCAM will be used for evaluation.

Detailed Description

New bioactive resin pits and fissures sealant BioCoat® by Premier® presenting SmartCap™ Technology involving semi-permeable resin microcapsules. The rechargeable SmartCap microcapsules are filled with ionic solutions of fluoride, calcium and phosphate, supposing greater fluoride uptake in the presence of calcium and phosphate ions.

With no enough evidence based information in literature about using bioactive fissure sealants in susceptible fissures , it isd beneficial to evaluate the newly introduced material using a randomized clinical trial to test the null hypothesis that bioactive resin pit and fissure sealant will have the same clinical performance as flouride releasing filled resin based pit and fissure sealant in susceptible fissures.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Inclusion Criteria of participants:

    • Patients with caries susceptible fiss- ures in fully erupted first permanent molars showing nosigns of caries.
    • Co-operative patients approving to part- icipate in the trial.
    • Good oral hygiene.
  • Inclusion Criteria of teeth:

    • Caries susceptible occlusal pits and fissures.
    • Intact contact with opposing teeth.
    • Teeth with no previous restorations in other surfaces.
Read More
Exclusion Criteria
  • Exclusion criteria of participants:

    • patients with Disabilities, systemic disease or severe medical complications.
    • patients have allergic history concerning methacrylate.
    • patients with rampant caries, xerostomia, evidence of severe bruxism, clenching, or tempromandibular joint disorders
    • participants who show lack of compliance.
  • Exclusion criteria of teeth:

    • Carious pits and fissures.
    • Developmental tooth defect.
    • Partially erupted teeth
    • Periapical pathology or signs of pulpal pathology.
    • Tooth hypersensitivity.
    • Heavy occlusion and occlusal contacts.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control group (A)UltraSeal XT™ plus by UltradentFluoride releasing filled resin based pit and fissure sealant using UltraSeal XT™ plus by Ultradent
Interventional group (B)BioCoat® by Premier®Bioactive pit and fissure sealant using BioCoat® by Premier®
Primary Outcome Measures
NameTimeMethod
Retention of sealant1 year

rate of sealant loss

Secondary Outcome Measures
NameTimeMethod
Caries incidence1 year

Rate of caries progression

© Copyright 2025. All Rights Reserved by MedPath